FuelCell Energy FCEL is trading below its 50-day and 200-day simple moving average (SMA), signaling a bearish trend. FCEL ...

The conditions for the railway technology spin out were drawn up over recent months at SMA and a corresponding spin out plan was agreed at the general meeting on April the 30th, 2008. The spin out of ...

The Clorox Company CLX is trading above its 200-day simple moving average (SMA), signaling a bullish trend. The company's ...

The conditions for the railway technology spin out were drawn up over recent months at SMA and a corresponding spin out plan was agreed at the general meeting on April the 30th, 2008. The spin out of ...

SMA Solar Technology plans to cut up to 1,100 jobs worldwide and lowered forecasts for the year, the German solar power parts supplier said on Wednesday, nearly two months after it announced a ...

Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for ...

OXY is exposed to commodity price fluctuation, but investors can remain invested, given its strong Permian Basin and contribution from acquired assets.

马萨诸塞州剑桥 - 拥有75.6%高毛利率的208亿美元生物技术公司Biogen Inc. (NASDAQ: BIIB )已进入关键阶段，美国和欧洲监管机构正在审查其用于治疗脊髓性肌萎缩症 (SMA)的nusinersen药物的高剂量方案。美国食品和药物管理局 (FDA)已接受该公司的补充新药申请 (sNDA)，欧洲药品管理局 (EMA)也已验证同一申请。

The company also plans to initiate the Phase 2 OPAL trial in mid-2025 to study apitegromab in SMA patients under two years of age. Apitegromab is a fully human monoclonal antibody that inhibits ...

Organic growth and continued investments in research and development of new products are assisting the company in providing efficient power management solutions to its clients. The 200-day SMA is ...

DLTR's store and product expansion is promising, yet rising expenses and soft discretionary demand weigh on performance.